Perthera
Curated by SignalPersonalized molecular cancer profiling through genomics and proteomics
Overview
Personalized molecular cancer profiling through genomics and proteomics. Through the company’s PrecisOn process, Perthera will provide oncologists with a comprehensive understanding of the molecular architecture of their patients’ tumors. The multiple molecular analyses of each tumor will be integrated into Perthera’s Expert Oncologist system (also known as ExpO), an expert learning database that sources the most current clinical knowledge and research/drug information available, to facilitate analysis of multi-omic molecular profiles in context with the patient’s medical history.
Key facts
- Founded
- 2012
- Headquarters
- Mclean, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view